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Abstract
Background: Lipoteichoic acid (LTA) is a component of gram-positive bacterial cell walls and may be elevated in
the cerebrospinal fluid of patients suffering from meningitis. Among matrix metalloproteinases (MMPs), MMP-9 has
been observed in patients with brain inflammatory diseases and may contribute to the pathology of brain diseases.
Moreover, several studies have suggested that increased oxidative stress is implicated in the pathogenesis of brain
inflammation and injury. However, the molecular mechanisms underlying LTA-induced redox signal and MMP-9
expression in brain astrocytes remain unclear.
Objective: Herein we explored whether LTA-induced MMP-9 expression was mediated through redox signals in rat
brain astrocytes (RBA-1 cells).
Methods: Upregulation of MMP-9 by LTA was evaluated by zymographic and RT-PCR analyses. Next, the MMP-9
regulatory pathways were investigated by pretreatment with pharmacological inhibitors or transfection with small
interfering RNAs (siRNAs), Western blotting, and chromatin immunoprecipitation (ChIP)-PCR and promoter activity
reporter assays. Moreover, we determined the cell functional changes by migration assay.
Results: These results showed that LTA induced MMP-9 expression via a PKC(α)-dependent pathway. We further
demonstrated that PKCα stimulated p47
phox/NADPH oxidase 2 (Nox2)-dependent reactive oxygen species (ROS)
generation and then activated the ATF2/AP-1 signals. The activated-ATF2 bound to the AP-1-binding site of MMP-9
promoter, and thereby turned on MMP-9 gene transcription. Additionally, the co-activator p300 also contributed to
these responses. Functionally, LTA-induced MMP-9 expression enhanced astrocytic migration.
Conclusion: These results demonstrated that in RBA-1 cells, activation of ATF2/AP-1 by the PKC(α)-mediated Nox
(2)/ROS signals is essential for upregulation of MMP-9 and cell migration enhanced by LTA.
Background
Matrix metalloproteinases (MMPs) comprise a family of
calcium- and zinc-dependent proteinases, and are in-
volved in normal development and wound healing as
well as in pathological conditions such as atherosclerosis
and metastasis. In brain, MMP-9 has been shown to be
upregulated during various CNS diseases [1,2]. Previous
reports have indicated that a series of functional elem-
ent-binding sites have been identified, including NF-κB,
Ets and AP-1 within the MMP-9 promoter [3], which
can be regulated by diverse stimuli. Moreover, proin-
flammatory factors including cytokines, endotoxins and
oxidative stress have been reported to upregulate MMP-
9 in astrocytes in vitro [4-6], implying that MMP-9 ac-
tivity may be regulated by diverse factors in the CNS
during neuroinflammation.
It is worth noting that bacterial infections have been
found to trigger brain inflammatory diseases [7]. Gram-
positive bacterial infections of the CNS occur in bacterial
meningitis and brain abscess, being localized to the mem-
branes surrounding the brain or in its parenchyma,
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trocytes and microglia are regarded as targets in gram-
positive bacterial infection [9,10]. Lipoteichoic acid (LTA)
is a major component of gram-positive bacterial cell walls
that induces glial inflammatory activation in vitro and
in vivo [11], mediated through TLR2 signaling [12]. In
astrocytes, TLR signaling has been shown to be involved
in brain inflammatory responses [13], accompanied by
upregulation of several genes with proinflammatory and
proapoptotic capabilities [14]. However, the role of MMP-
9 in astrocytes, the major regulator of fundamental bio-
logical functions of the CNS [15], in LTA-induced brain
inflammation remains poorly defined.
TLR2 is believed to be responsible for LTA recogni-
tion challenged by gram-positive bacteria such as
Staphylococcus aureus and Streptococcus pneumouniae
[16]. Upon binding to TLR heterodimers (i.e., TLR2/
TLR1 or TLR2/TLR6 complex), LTA exerts a sequential
activation of members of IL-1 receptor-associated kin-
ase (IRAK) family and tumor necrosis factor receptor-
associated factor 6 (TRAF6), mediated by a TLR adaptor
protein, MyD88. Ultimately, TLR signaling activates the
MAPK family, NF-κB and AP-1, leading to expression
of cytokines and other proinflammatory proteins [7,8].
Our previous studies have demonstrated that interleukin-1
(IL-1β), bradykinin (BK) and oxidized low-density
lipoprotein (oxLDL) upregulate MMP-9 expression via
NF-κB, Elk-1 and AP-1 signaling in rat astrocytes
[4,17,18]. In response to pathogenic ligands, TLR2/
MyD88 activates PI3K/Akt, MAPKs and NF-κB path-
ways, which modulate immune responses following lig-
and recognition [16,19]. Moreover, activation of these
signaling cascades and transcription factors has been
reported to be involved in induction of MMP-9 in rat
astrocytes [4,17,18]. A recent report has shown that
LTA increases MMP-9 expression via the ERK pathway
in RAW 264.7 macrophages [20]. However, the mechan-
isms underlying the regulation of MMP-9 expression by
LTA in astrocytes are still unclear.
Reactive oxygen species (ROS) are produced by various
enzymatic reactions such as NADPH oxidase (Nox). ROS
are essential for many physiological functions and killing
invading microorganisms [21,22]. Under pathological con-
ditions, increasing ROS production by external stimuli can
regulate the expression of several inflammatory genes dur-
ing brain injury [23-25]. Recently, increasing evidence has
attributed the cellular damage in neurodegenerative disor-
ders such as AD to oxidative stress, which leads to the
generation of free radicals, which are responsible for brain
inflammatory disorders [24,25]. Although the effects of
LTA on ROS generation have been reported in tracheal
smooth muscle cells and renal diseases [26,27], LTA-
induced astrocytic responses through the ROS signal are
not well characterized.
Here we investigate the molecular mechanisms under-
lying LTA-induced MMP-9 expression in cultured RBA-
1 cells. These findings demonstrate that in RBA-1 cells,
LTA-induced MMP-9 expression is mediated through
PKCα and Nox2-dependent generation of the ROS sig-
naling pathway, and ATF2/AP-1. Moreover, upregulation
of MMP-9 expression is positively associated with cell
migration in these cells.
Methods
Materials
DMEM/F-12 medium, FBS, TRIzol and siRNAs of
PKCα, p47
phox, Nox1, Nox2, Nox4, ATF2 and p300 were
from Invitrogen (Carlsbad, CA). Hybond C membrane
and the ECL Western blotting detection system were
from GE Healthcare Biosciences (Buckinghamshire, UK).
MMP-9 antibody was from NeoMarker (Fremont, CA).
PKCα and phospho-ATF2 antibodies were from Cell Sig-
naling (Danver, MA). p47
phox, Nox2 and phospho-p300
antibodies were from Santa Cruz (Santa Cruz, CA).
GAPDH antibody was from Biogenesis (Boumemouth,
UK). GF109203X, Gö6976, apocynin, diphenylene iodo-
nium (DPI), tanshinone IIA (TSIIA) and GR343 were
from Biomol (Plymouth Meeting, PA). Bicinchoninic
acid (BCA) protein assay reagent was from Pierce (Rock-
ford, IL). LTA (from Staphylococcus aureus), N-acetyl
cysteine (NAC), enzymes and other chemicals were from
Sigma (St. Louis, MO).
Cell cultures
The rat brain astrocytic cell line (RBA-1) originated
from a primary astrocyte culture of neonatal rat cere-
brum, and was naturally developed through successive
cell passages [28] and used throughout this study. Pri-
mary astrocyte cultures were prepared from the cortex
of 6-day-old Sprague–Dawley rat pups [29]. Rats were
maintained according to the Guidelines of the Animal
Care Committee of Chang Gung University and the Na-
tional Institutes of Health Guide for the Care and Use of
Laboratory Animals. The purity of primary astrocyte cul-
tures was assessed using an astrocyte-specific marker,
GFAP, showing over 95% GFAP-positive astrocytes. Cells
were plated onto 12-well culture plates and made quies-
cent at confluence by incubation in serum-free DMEM/
F-12 for 24 h. Growth-arrested cells were incubated with
LTA at 37°C for the indicated time intervals. When the
inhibitors were used, cells were pretreated with the in-
hibitor for 1 h before exposure to LTA.
MMP gelatin zymography
Growth-arrested cells were incubated with LTA for the
indicated time intervals. Treatment of RBA-1 cells with
pharmacological inhibitors or LTA alone had no signifi-
cant effect on cell viability determined by an XTT assay
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gelatin zymography [29]. Gelatinolytic activity was mani-
fested as horizontal white bands on a blue background.
Because cleaved MMPs were not reliably detectable, only
pro-form zymogens were quantified.
Total RNA extraction and reverse transcription PCR
analysis
Total RNA was extracted from RBA-1 cells [29]. The cDNA
obtained from 0.5 μg total RNA was used as a template for
PCR amplification. Oligonucleotide primers were designed
based on Genbank entries for rat MMP-9, Nox1-4 [30] and
β-actin. The following primers were used for amplification
r e a c t i o n :M M P - 9 ,5 ′-AGTTTGGTGTCGCGGAGCAC-3′
(sense), 5′-TACATGAGCGCTTCCGGCAC-3′ (antisense);
Nox1, 5′-TACGAAGTGGCTGTACTGGTTG-3′ (sense),
5′-CTCCCAAAGGAGGTTTTCTGTT-3′ (antisense);
Nox2, 5′-TCAAGTGTCCCCAGGTATCC-3′ (sense), 5′-
CTTCACTGGCTGTACCAAAGG-3′ (antisense); Nox3,
5′-AATCACAGAGTCTGCCTGGACT-3′ (sense), 5′-ATC-
CAGACTTTCATCCCAGTGT-3′ (antisense); Nox4, 5′-
GGAAGTCCATTTGAGGAGTCAC-3′ (sense), 5′-
TGGATGTTCACAAAGTCAGGTC-3′ (antisense); β-actin,
5′-GAACCCTAAGGCCAACCGTG-3′ (sense) and 5′-
TGGCATAGAGGTCTTTACGG-3′ (antisense). The ampli-
fication was performed in 30 cycles at 55°C, 30 s; 72°C, 1
min; 94°C, 30s. PCR fragments were analyzed on 2% agarose
in 1X TAE gel containing ethidium bromide, and their size
was compared to molecular weight markers. Amplification
of β-actin, a relatively invariant internal reference RNA, was
performed in parallel, and cDNA amounts were standardized
to equivalent β-actin mRNA levels. These primer sets specif-
ically recognize only the genes of interest as indicated by
amplification of a single band of the expected size (754 bp
for MMP-9, 337 bp for Nox1, 209 bp for Nox2, 214 bp for
Nox3, 244 bp for Nox4 and 514 bp for β-actin) and direct
sequence analysis of the PCR product. Real-time PCR was
performed with the TaqMan gene expression assay system,
using primers and probe mixes for MMP-9 and endogenous
GAPDH control genes. PCRs were performed using the
7500 Real-Time PCR System (Applied Biosystems, Foster
City, CA). The primers were: 5′-(TGATGCCATTGCT-
GATATCCA)-3′ (sense), 5′-(CGGATCCTCAAAGGCT-
GAGT)-3′ (anti-sense) for MMP-9; 5′-
(AACTTTGGCATCGTGGAAGG)-3′ (sense), 5′-
(GTGGATGCAGGGATGATGTTC)-3′ (anti-sense) for
GAPDH. Relative gene expression was determined by the
ΔΔCt method, where Ct meant threshold cycle. All experi-
ments were performed in triplicate (n=3).
Preparation of cell extracts and western blotting analysis
Growth-arrested cells were incubated with LTA for the
indicated time intervals. The cell lysates were collected
and the protein concentration was determined by the
BCA reagents. Samples from these cell lysates (30 μg
protein) were denatured and subjected to SDS-PAGE
using a 10% (w/v) running gel. The phosphorylation of
serine, ATF2, and p300 or total Nox, p47
phox, PKCα,
ATF2 and p300 were identified and quantified by West-
ern blotting as previously described [29]. The immunor-
eactive bands were detected by the UVP Biospectrum
W
imaging system (Upland, CA).
Measurement of intracellular ROS generation
The peroxide-sensitive fluorescent probe 2′,7′-dichloro-
fluorescein diacetate (DCF-DA) was used to assess the
generation of intracellular ROS [31] with minor modifi-
cations. RBA-1 cells in monolayers were incubated with
RPMI-1640 supplemented with 5 μM DCF-DA for 45
min at 37°C. The supernatant was replaced with fresh
RPMI-1640 medium before stimulation with LTA (50
μg/ml). Relative fluorescence intensity was recorded over
time (0–60 min) by using a fluorescent plate reader
(Thermo, Appliskan) at an excitation wavelength of 485
nm, and emission was measured at a wavelength of 530
nm. Fluorescent images were also obtained by using
fluorescence microscopy (ZEISS, Axiovert 200 M). The
data presented are generated from three separate assays
(n=3).
Determination of NADPH oxidase activity by
chemiluminescence assay
The NADPH oxidase activity in intact cells was assayed
by lucigenin chemiluminescence assay as described pre-
viously [32] with modifications. After incubation, the
cells were gently scraped and centrifuged at 400×g for
10 min at 4°C. The cell pellet was resuspended in a vol-
ume (35 μl/well) of ice-cold RPMI 1640 medium, and
the cell suspension was kept on ice. To a final 200 μl
volume of pre-warmed (37°C) RPMI 1640 medium con-
taining either NADPH (1 μM) or lucigenin (20 μM), 5 μl
of cell suspension (2×10
4 cells) was added to initiate the
reaction followed by immediate measurement of chemi-
luminescence in a Appliskan luminometer (Thermo
W)i n
out-of-coincidence mode. Appropriate blanks and con-
trols were established, and chemiluminescence was
recorded. Neither NADPH nor NADH enhanced the
background chemiluminescence of lucigenin alone (30–
40 counts/min). Chemiluminescence was continuously
measured for 12 min, and the activity of NADPH oxi-
dase was expressed as counts per million cells.
Isolation of cell fraction
After treatment, cells were harvested, sonicated for 5 s
at output 1.5 with a sonicator (Misonix, Inc., Farming-
dale, NY) and centrifuged at 8,000 rpm for 15 min at 4°
C. The pellet was collected as the nuclear fraction. The
supernatant was centrifuged at 14,000 rpm for 60 min at
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supernatant (cytosolic fraction).
Immunofluorescence staining
Growth-arrested cells were treated with LTA (50 μg/ml),
washed twice with ice-cold PBS, fixed with 4% (w/v) par-
aformaldehyde in PBS for 30 min and then permeabi-
lized with 0.3% Triton X-100 in PBS for 15 min. The
staining was performed by incubating with 10% normal
goat serum in PBS for 30 min followed by incubating
with an anti-p47
phox polyclonal antibody (1:200 dilution)
for 1 h in PBS with 1% BSA, washing three times with
PBS, incubating for 1 h with fluorescein isothiocyanate
(FITC)-conjugated goat anti-rabbit antibody (1:200 dilu-
tion) in PBS with 1% BSA, washing three times with PBS
and finally mounting with aqueous mounting medium.
The images were observed under a fluorescence micro-
scope (ZEISS, Axiovert 200 M). The data presented are
generated from three separate assays (n=3).
Transient transfection with siRNAs
The small interfering RNA (siRNA) duplexes corre-
sponding to rat PKCα, p47
phox, Nox1-4, ATF2, p300 and
scrambled siRNA were from Invitrogen (Invitrogen,
Carlsbad, CA). Transient transfection of siRNAs (100
nM) was carried out using Lipofetamine
TM RNAiMAX
reagent according to the manufacturer’s instructions
(n=3).
Plasmid construction, transient transfection and promoter
activity assay
The upstream region (−1280 to +19) of the rat MMP-9
promoter was cloned to the pGL3-basic vector contain-
ing the luciferase reporter system. Briefly, a 1.3-kb seg-
ment at the 5′-flanking region of the rat MMP-9 gene
was amplified by PCR using specific primers from the
rat MMP-9 gene (accession no. U36476): 5′-ccccggtacc-
GAAGGCGAAATGCTTTGCCC (forward/Kpn1) and
5′-ccccctcgaGGGTGAGAACCGAAGCTTCTG (re-
verse/Xho1). The pGL3-Basic vector, containing a polya-
denylation signal upstream from the luciferase gene, was
used to construct the expression vectors by subcloning
PCR-amplified DNA of the MMP-9 promoter into the
Kpn1/Xho1 site of this vector. The PCR products
(pGL3-MMP-9WT) were confirmed by their size, as
determined by electrophoresis, and by DNA sequencing.
All plasmids were prepared by using QIAGEN plasmid
DNA preparation kits. The MMP-9-luc constructs were
transfected into RBA-1 cells, respectively, using a Lipo-
fectamine reagent according to the manufacturer’s
instructions. The transfection efficiency (~60%) was
determined by transfection with enhanced GFP. After
incubation with LTA (50 ng/ml), cells were collected and
disrupted by sonication in lysis buffer (25 mM Tris, pH
7.8, 2 mM EDTA, 1% Triton X-100 and 10% glycerol).
After centrifugation, aliquots of the supernatants were
tested for luciferase activity using the luciferase assay
system. Firefly luciferase activities were standardized for
β-galactosidase activity. The data presented are gener-
ated from three separate assays (n=3).
Chromatin immunoprecipitation assay
To detect the in vivo association of nuclear proteins with
rat mmp-9 promoter, chromatin immunoprecipitation
(ChIP) analysis was conducted as described previously
[17]. RBA-1 cells in 100-mm dishes were grown to con-
fluence and serum starved for 24 h. After treatment with
LTA, protein-DNA complexes were fixed by 1% formal-
dehyde in PBS. The fixed cells were washed and lysed in
SDS-lysis buffer (1% SDS, 5 mM EDTA, 1 mM PMSF,
50 mM Tris–HCl, pH 8.1) and sonicated on ice until the
DNA size became 200–1,000 base pairs. The samples
were centrifuged, and the soluble chromatin was pre-
cleared by incubation with sheared salmon sperm DNA-
protein agarose A slurry (Upstate) for 30 min at 4°C
with rotation. After centrifugation at 800 rpm for 1 min,
one portion of the pre-cleared supernatant was used as
DNA input control, and the remains were subdivided
into aliquots and then incubated with a non-immune
rabbit immunoglobulin G (IgG; Santa Cruz), anti-ATF2
(Santa Cruz), respectively, for overnight at 4°C. The
immunoprecipitated complexes of Ab-protein-DNA
were collected by using the above protein A beads and
washed successively with low-salt buffer (0.1% SDS, 1%
Triton X-100, 2 mM EDTA, 20 mM Tris–HCl, pH 8.1,
150 mM NaCl), high-salt buffer (same as the low-salt
buffer but with 500 mM NaCl), LiCl buffer (0.25 M LiCl,
1% NP-40, 1% deoxycholate, 1 mM EDTA, 10 mM Tris–
HCl, pH 8.1) and Tris-EDTA (pH 8.0), and then eluted
with elution buffer (1% SDS, 100 mM NaHCO3). The
cross-linking of protein-DNA complexes was reversed
by incubation with 5 M NaCl at 65°C for 4 h, and DNA
was digested with 10 μg of proteinase K (Sigma)/ml for
1 h at 45°C. The DNA was then extracted with phenol-
chloroform, and the purified DNA pellet was precipi-
tated with isopropanol. After washing, the DNA pellet
was resuspended in H2O and subjected to PCR amplification
with the forward (5′-AGAGCCTGCTCCCAGAGGGC-3′)
and reverse (5′-GCCAAGTCAGGCAGGACCCC-3′), which
were specifically designed from the distal AP-1 mmp-9 pro-
moter region (−557 to −247). PCR products were analyzed on
ethidium bromide-stained agarose gels (n=3).
Migration assay
RBA-1 cells were cultured to confluence in 10-cm dishes
and starved with serum-free DMEM/F-12 medium for
24 h. The monolayer cells were scratched manually with
a blade to create extended and definite scratches in the
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detached cells were removed by washing the cells once
with PBS. Serum-free DMEM/F-12 medium with or
without LTA (50 μg/ml) was added to each dish as indi-
cated after pretreatment with the inhibitors for 1 h, con-
taining a DNA synthesis inhibitor hydroxyurea (10 μM)
in the whole course. Images of migratory cells from the
scratch boundary were observed and acquired at 0 and
48 h with a digital camera and a light microscope
(Olympus, Japan). The number of migratory cells was
counted from the resulting four phase images for each
point and then averaged for each experimental condi-
tion. The data presented are generated from three separ-
ate assays.
Statistical analysis of data
Data were estimated using a GraphPad Prism Program
(GraphPad, San Diego, CA, USA). Quantitative data
were analyzed using ANOVA followed by Tukey’s hon-
estly significant difference tests between individual
groups. Data were expressed as mean±SEM of three in-
dependent experiments (n=3). A value of P<0.05 was
considered significant.
Results
ROS signal is essential for LTA-induced MMP-9 expression
in RBA-1 cells
ROS have been shown to induce MMPs expression in
various cell types [33]. To determine whether ROS parti-
cipated in MMP-9 induction, pretreatment of RBA-1
cells with N-acetylcysteine (NAC, a ROS scavenger, 10
mM) attenuated the LTA-induced MMP-9 protein and
mRNA expression (Figure 1a and b), suggesting that
ROS may play a crucial role in LTA-induced MMP-9 ex-
pression in RBA-1 cells. To determine whether LTA sti-
mulates intracellular ROS generation, as shown in
Figure 1c, LTA stimulated ROS generation in a time-
dependent manner that was markedly attenuated by pre-
treatment with NAC, indicating that LTA stimulated
ROS generation. To demonstrate whether LTA-induced
MMP-9 expression via the ROS-dependent pathway also
occurred in primary cultured astrocytes, as shown in
Figure 1d, pretreatment with NAC concentration-
dependently inhibited LTA-induced MMP-9 expression
in primary cultured astrocytes. To demonstrate the func-
tional activity of MMP-9 induced by LTA, we evaluated
cell migration of primary culture astrocytes. The images
of cell migration were taken and counted at 48 h induc-
tion by LTA (50 μg/ml). As shown in Figure 1d (lower
panel), LTA-induced cell migration was significantly
blocked by pretreatment with the inhibitors of MMP2/9
(2/9i, 1 μM) or ROS (NAC, 10 mM). These data sug-
gested that upregulation of MMP-9 and its activity via
the ROS-dependent pathway is required for enhancing
cell migration induced by LTA in brain astrocytes. Taken
together, these results demonstrated that LTA-induced
responses in rat primary cultured astrocytes are similar
to those of RBA-1 cells. Thus, the following experiments
were performed using RBA-1 cells, which can be applied
as a model throughout this study.
Nox2-derived ROS generation is involved in LTA-induced
MMP-9 expression
NADPH oxidase (Nox) is considered to be a major
source of ROS in several physiological and pathological
processes [21,34]. To further explore whether LTA-
induced MMP-9 expression mediated through activation
of Nox activation, as shown in Figure 2a and b, pretreat-
ment with a Nox activity inhibitor diphenyleneiodonium
(DPI, 1 μM) or p47
phox inhibitor apocynin (Apo, 10 μM)
significantly attenuated the LTA-induced MMP-9 pro-
tein and mRNA expression in RBA-1 cells. To further
demonstrate whether LTA stimulates p47
phox-mediated
Nox activity, as shown in Figure 2c, LTA stimulated Nox
activity and ROS generation, which was attenuated by
pretreatment with DPI (1 μM) or Apo (10 μM), sug-
gesting that p47
phox/Nox-derived ROS is involved in
LTA-induced MMP-9 expression in RBA-1 cells. To de-
termine which Nox isotypes are involved in these
responses, the expression of Nox isotypes was analyzed,
and transfection with Nox siRNA was performed. First,
we found that Nox1, Nox2 and Nox4 were expressed in
RBA-1 cells and Nox2 was predominantly expressed in
comparison to the other two determined by RT-PCR
(data not shown). Next, transfection with Nox2 siRNA
knocked down the expression of Nox2 protein and sig-
nificantly attenuated LTA-induced MMP-9 expression in
RBA-1 cells (Figure 2d). These results suggested that
LTA-induced MMP-9 expression is mediated through
Nox2-dependent ROS generation in these cells.
Involvement of p47
phox in LTA-induced MMP-9 expression
Moreover, phosphorylation and translocation of p47
phox
to plasma membrane are important events in the activa-
tion of Nox [35,36]. Therefore, we first determined
whether LTA stimulates p47
phox phosphorylation at
serine residues; as shown in Figure 3a, LTA stimulated
p47
phox serine phosphorylation in a time-dependent
manner, which was attenuated by pretreatment with
Apo (10 μM). We next determined the effect of LTA on
translocation of p47
phox; cells were treated with LTA for
10 min in the absence or presence of Apo. The mem-
brane fraction was analyzed by Western blot using an
anti-phospho-serine (p-Ser) or anti-p47
phox antibody.
LTA stimulated a significant translocation of p47
phox
from the cytosol to the membrane with a maximal re-
sponse within 10 min, which was attenuated by pretreat-
ment with Apo (Figure 3b, left part). The results were
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obtained using fluorescent microscopy (Figure 3b, right
part). Moreover, to further demonstrate the role of
p47
phox in the MMP-9 induction by LTA, as shown in
Figure 3c, transfection with p47
phox siRNA knocked
down the expression of p47
phox protein and significantly
attenuated LTA-induced MMP-9 expression. These
results suggested that p47
phox/Nox-dependent ROS gen-
eration plays a crucial role in LTA-induced MMP-9 ex-
pression in RBA-1 cells.
LTA induces MMP-9 expression via PKCα-dependent
pathway
Several PKC isoforms such as PKC-α have been shown
to regulate MMP-9 expression in various cell types [37].
Recent reports also suggested that activation of Nox/
ROS signaling might be mediated through PKC [36,38].
Here we further demonstrated which PKC isoforms are
involved in LTA-induced Nox/ROS generation and
MMP-9 expression. Pretreatment with either a pan-PKC
inhibitor GF109203X (30 μM) or a selective PKCα in-
hibitor Gö6976 (1 μM) significantly inhibited LTA-
induced MMP-9 expression (Figure 4a) as revealed by
zymography, suggesting that PKC (PKC-α especially)
plays a potential role in LTA-induced MMP-9 expres-
sion. LTA also stimulated PKCα translocation from the
cytosol to the membrane in a time-dependent manner
with a maximal increase within 10–15 min (Figure 4b,
upper part), which was attenuated by pretreatment with
Gö6976 (1 μM) (Figure 4b, lower part), confirming the
involvement of PKCα in LTA-induced MMP-9 expres-
sion in RBA-1 cells. We further examined the role of
PKC(α) in LTA-stimulated Nox activity and ROS gener-
ation; as shown in Figure 4c, LTA-stimulated Nox acti-
vation and ROS generation were blocked by
pretreatment with GF109203X (GF, 30 μM) or Gö6976
Figure 1 ROS are essential for LTA-induced MMP-9 expression in RBA-1 cells. a Cells were pretreated with or without N-acetylcysteine
(NAC, 10 mM) for 1 h before exposure to 50 μg/ml LTA for the indicated time intervals. The conditioned media were analyzed by gelatin
zymography for MMP-9 expression and activity. b Cells were treated with or without NAC (10 mM) for 1 h before exposure to 50 μg/ml LTA for
16 h. The total RNA was analyzed by RT-PCR (upper panel) and real-time RT-PCR (lower panel). c Cells were incubated with the peroxide-sensitive
fluorescent probe DCF-DA (5 μM) for 45 min, followed by stimulation with 50 μg/ml LTA for the indicated time intervals or for 15 min in
presence or absence of 10 mM NAC. The fluorescence intensity of cells was determined. d Rat primary astrocytes were isolated and cultured, and
pretreated with or without NAC (1 or 10 mM) before exposure to LTA for 16 h. The conditioned media were analyzed by gelatin zymography
(upper panel). For cell migration, cells were plated on coverslips and grown to confluence, then the coverslips were transferred to a new 10-cm
dish containing serum-free medium for 24 h. Cells were pretreated with MMP2/9 inhibitor (2/9i) or NAC for 1 h and then incubated with LTA (50
μg/ml) for 48 h. Phase contrast images of cells were taken. The number of LTA-induced cell migrations was counted (lower panel). Data are
expressed as the mean±SEM of three independent experiments.
*P<0.05;
#P<0.01, as compared with the respective values of cells stimulated
with vehicle (c) or LTA alone (c, d). The figure represents one of three similar experiments.
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phox at
serine residues mediated through PKC-α, as shown in
Figure 4d, LTA-stimulated phosphorylation of serine
residues on p47
phox was attenuated by pretreatment with
Gö6976 (1 μM). To confirm the role of PKCα in MMP-9
induction by LTA, as shown in Figure 4e, transfection
with PKCα siRNA knocked down the expression of
PKCα protein and significantly attenuated LTA-induced
MMP-9 expression. These results demonstrated that
PKCα participates in LTA-induced Nox/ROS generation
and MMP-9 expression in RBA-1 cells.
ATF-2/AP-1 is required for LTA-induced MMP-9 expression
in RBA-1 cells
Activating transcription factor (ATF) subfamily (ATFa,
ATF-1 ATF-2 and ATF-3) is a member of AP-1 tran-
scription factor complex. ATF-2 and Fos proteins are
commonly seen in pathological processes. However,
the role of ATF-2 in LTA-induced MMP-9 expression
is still unknown. Thus, we investigated whether ATF2
is involved in LTA-induced MMP-9 expression in
RBA-1 cells; as shown in Figure 5a, transfection with
ATF-2 siRNA downregulated ATF-2 protein expression
and significantly attenuated LTA-induced MMP-9 ex-
pression in RBA-1 cells, suggesting that ATF2/AP-1 is
an important factor in LTA-induced MMP-9 expres-
sion. To determine whether the phosphorylation of
ATF-2 is essential for LTA-induced MMP-9 expression,
we found that LTA stimulated phosphorylation of
ATF2 in a time-dependent manner. There was a sig-
nificant increase within 60 min and reached a maximal
response by 90 min (Figure 5b). Pretreatment with an
AP-1 inhibitor TSIIA (10 μM) markedly attenuated
LTA-stimulated ATF-2 phosphorylation (Figure 5c). To
Figure 2 NADPH oxidase (Nox)-dependent ROS generation is involved in LTA-induced MMP-9 expression in RBA-1 cells. a Cells were
pretreated with or without DPI (1 μM) or apocynin (Apo, 10 μM) for 1 h before exposure to LTA (50 μg/ml) for the indicated time intervals. The
conditioned media were analyzed by gelatin zymography for MMP-9 expression and activity. b The total RNA was collected and MMP-9 mRNA
expression analyzed by RT-PCR (upper panel) and real-time RT-PCR (lower panel). c Cells were pretreated with or without DPI (1 μM) or apocynin
(Apo, 10 μM) for 1 h before exposure to 50 μg/ml LTA for 15 min. The Nox activity and ROS generation were analyzed. d Cells were transfected
with scramble (scra) or Nox2 siRNA for 24 h, followed by stimulation with LTA for 16 h. The conditioned media and cell lysates were collected for
gelatin zymography or Western blotting analysis of Nox2 and GAPDH (as an internal control). Data are expressed as the mean±SEM of three
independent experiments.
*P<0.05;
#P<0.01, as compared with the r cells stimulated with LTA (c) alone. The figure represents one of three
similar experiments.
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http://www.jneuroinflammation.com/content/9/1/110determine whether PKC and Nox/ROS are involved in
LTA-stimulated ATF-2 phosphorylation, as shown in
Figure 5c, pretreatment with Gö6976 (1 μM), NAC
(10 mM), DPI (1 μM) or Apo (10 μM) attenuated
LTA-stimulated ATF-2 phosphorylation, indicating that
LTA-stimulated ATF-2/AP-1 phosphorylation was mediated
through the PKCα/Nox/ROS cascade in RBA-1 cells.
Here we also used the ChIP-PCR assay to determine
whether ATF2/AP-1 is involved in LTA-induced MMP-
9 gene expression. We first designed a pair of primers
for MMP-9 promoter (−597 to −318), containing an
AP-1 binding site. Chromatin was immunoprecipitated
using an anti-phospho-ATF-2 antibody, and the MMP-
9p r o m o t e rr e g i o n( −597 to −318) was amplified by PCR.
As shown in Figure 5d, in vivo binding of phospho-
ATF-2 to the MMP-9 promoter was time-dependently
increased by LTA, which was attenuated by NAC
(Figure 5d). These results suggested that ROS-
dependent signaling is involved in LTA-induced ATF-
2/AP-1 binding to the MMP-9 promoter in RBA-1
cells.
The transcriptional co-activator p300 is crucial for
LTA-induced MMP-9 expression
Several studies have reported that p300, a transcriptional
co-activator, plays a critical role in many gene transcrip-
tion-regulating events [39]. Hence, we also investigated
the role of p300 in LTA-induced MMP-9 expression.
Pretreatment with the p300 inhibitor garcinol (GR343,
0.1-10 μM) concentration-dependently inhibited LTA-
induced MMP-9 expression (Figure 6a). To determine
whether the phosphorylation of p300 is essential for
LTA-induced MMP-9 expression, we found that LTA sti-
mulated phosphorylation of p300 in a time-dependent
manner (Figure 6b). To determine whether PKC and
Nox/ROS are involved in LTA-stimulated p300 phos-
phorylation, as shown in Figure 6c, pretreatment with
Gö6976 (1 μM), DPI (1 μM), NAC (10 mM) or Apo (10
Figure 3 Involvement of p47
phox translocation in LTA-induced MMP-9 expression. Cells were pretreated without or with Apo (10 μM) for 1
h and then stimulated with 50 μg/ml LTA for the indicated time intervals or 10 min. a The whole cell lysates and (b) the membrane fraction were
prepared and analyzed by Western blotting using an anti-phospho-serine (p-Ser), p47
phox or Gαs (as a membrane control) antibody. The p47
phox
translocation was also observed by immunofluorescent staining. c Cells were transfected with scramble (scra) or p47
phox siRNA for 24 h, followed
by stimulation with LTA for 16 h. The conditioned media and cell lysates were analyzed by gelatin zymography or Western blotting analysis of
p47
phox and GAPDH. Data are expressed as the mean of three independent experiments.
*P<0.05;
#P<0.01, as compared with the cells
stimulated with vehicle (a) and LTA (a, b) alone.
}P<0.01, as compared with the cells stimulated with LTA (a) alone. The figure represents one of
three similar experiments.
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http://www.jneuroinflammation.com/content/9/1/110μM) attenuated LTA-stimulated p300 phosphorylation,
indicating that LTA-stimulated p300 phosphorylation
was mediated through the PKCα/Nox/ROS cascade in
RBA-1 cells. To confirm the role of p300 in LTA-
induced MMP-9 expression, as shown in Figure 6d,
transfection with p300 siRNA knocked down the expres-
sion of p300 protein and inhibited MMP-9 induction by
LTA. These results demonstrated that the PKCα/Nox/
ROS-mediated p300 cascade plays an important role in
LTA-induced MMP-9 expression in RBA-1 cells.
LTA induces MMP-9 promoter activity and astrocytic
migration
We further investigated whether LTA-stimulated MMP-
9 transcription activity was also mediated through this
ROS-dependent pathway. The MMP-9 promoter was
constructed into a pGL3-basic vector containing the
luciferase reporter system (pGL-MMP-9-Luc), which
contained AP-1 binding sites. LTA-induced MMP-9 pro-
moter activity was attenuated by pretreatment with
Gö6976 (Gö, 1 μM), DPI (1 μM), apocynin (Apo, 10
Figure 4 LTA induces ROS generation and MMP-9 expression via PKCα.aCells were pretreated with or without GF109203X (GF, 30 μM) or
Gö6976 (Gö, 1 μM) for 1 h before exposure to 50 μg/ml LTA for the indicated time intervals. The conditioned media were analyzed by gelatin
zymography. b Cells were pretreated without or with Gö (1 μM) for 1 h and then incubated with LTA for the indicated time intervals (upper part)
or 10 min (lower part). The membrane and cytosol fractions were prepared and analyzed by Western blotting using anti-PKC-α,G αs (as a
membrane control) or GAPDH antibody. c Cells were pretreated with or without GF or Gö for 1 h before exposure to LTA for 15 min. The Nox
activity and ROS generation were analyzed. d Cells were pretreated with or without Gö (1 μM) for 1 h before exposure to LTA for the indicated
time intervals. e Cells were transfected with scramble (scra) or PKCα siRNA for 24 h, followed by stimulation with LTA for 16 h. The conditioned
media and cell lysates were analyzed by gelatin zymography or Western blotting analysis. The cell lysates were analyzed by Western blotting
using anti-phospho-serine (p-Ser), p47
phox or GAPDH antibody. Data are expressed as the mean±SEM of three independent experiments.
*P<0.01;
#P<0.01, as compared with the cells stimulated with LTA (c, d) alone. The figure represents one of three similar experiments.
Hsieh et al. Journal of Neuroinflammation 2012, 9:110 Page 9 of 16
http://www.jneuroinflammation.com/content/9/1/110μM), NAC (10 mM) or GR343 (10 μM) (Figure 7a). To
demonstrate the functional activity of MMP-9 induced
by LTA, we evaluated cell migration of RBA-1 cells. The
images of cell migration were taken and counted at 48 h
induction by LTA (50 μg/ml). As shown in Figure 7b,
LTA-induced cell migration was significantly blocked by
pretreatment with the inhibitors of MMP2/9 (2/9i),
PKCα (Gö, 1 μM), Nox (DPI, 1 μM), ROS (NAC, 10
mM) or p300 (GR, 10 μM). Taken together, these results
suggested that upregulation of MMP-9 and its activity
via the PKCα-dependent Nox/ROS and p300 pathway is
required for enhancing cell migration induced by LTA in
RBA-1 cells.
Discussion
Excessive MMP-9 expression and activity are associated
with sustained inflammation and BBB breakdown,
leading to brain injury. Blockade of MMP-9 activity by
pharmacological inhibitors or gene knockout strategies
provide protective effects against cerebral ischemia
[39,40]. Moreover, the gram-positive bacterium Strepto-
coccus pneumoniae is the most common cause of acute
bacterial meningitis worldwide [41,42], revealing a close
relationship between LTA challenges and CNS diseases.
The pathogenic progression involves glial activation and
TLR2 signaling stimulated by LTA, which are linked to
inflammatory neurodegeneration [9-11]. Additionally,
LTA exhibits detrimental effects on brain cellular func-
tions, including induction of apoptosis, production of
oxidative stresses and disruption of BBB following group
B Streptococcus or Staphylococcus aureus challenge in
the CNS [9-11]. Despite an obviously important role of
LTA in brain diseases, the processes by which LTA was
implicated in astrocytic functions are not completely
Figure 5 ATF-2/AP-1 is required for LTA-induced MMP-9 expression. a RBA-1 cells were transfected with scramble (scra) or ATF2 siRNA for
24 h, followed by stimulation with 50 μg/ml LTA for 16 h. The conditioned media and cell lysates were analyzed by gelatin zymography or
Western blotting. b Cells were treated with LTA for the indicated time intervals. c Cells were pretreated with or without tanshinone IIA (TSIIA, 10
μM), Gö6976 (1 μM), NAC (10 mM), DPI (1 μM) or apocynin (10 μM) for 1 h before exposure to LTA for the indicated time intervals. The cell
lysates were analyzed by Western blotting using an anti-phospho-ATF-2 (p-ATF2) or GAPDH antibody. d RBA-1 cells were pretreated with NAC
(10 mM) for 1 h and then incubated with LTA (50 μg/ml) for the indicated time intervals or 90 min. The ATF-2/AP-1 binding activity was analyzed
by chromatin-IP (ChIP)-PCR assay. Data are expressed as the mean of three independent experiments.
#P<0.01, as compared with the cells
stimulated with vehicle (b, d)o r
}P<0.05, as compared with the cells stimulated with LTA (d) alone. The figure represents one of three similar
experiments.
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http://www.jneuroinflammation.com/content/9/1/110understood. Thus, we investigated the mechanisms
underlying LTA-induced MMP-9 expression and its
effects. Our recent studies have demonstrated that c-
Src-dependent NF-κB and Ca
2+/CaMKII-dependent
JNK/c-Jun pathways mediate LTA-induced MMP-9 ex-
pression and cell migration in RBA-1 cells [43,44]. Here,
we further demonstrated that a PKCα/Nox2/ROS-
dependent ATF2/AP-1 and p300 pathway is also
involved in LTA-induced MMP-9 expression and cell
migration in brain astrocytes (Figure 7b). Based on these
findings, Figure 7c depicts a model for the PKCα-
mediated activation of p47
phox/Nox2/ROS-dependent
ATF2/AP-1 and p300 signaling pathway implicated in
LTA-induced MMP-9 expression and cell migration in
Figure 6 The transcriptional co-activator p300 contributes to LTA-induced MMP-9 expression. a Cells were pretreated with or without GR343
for 1 h before exposure to 50 μg/ml LTA for 16 h. The conditioned media were analyzed by gelatin zymography. b, c Cells were pretreated without or with
Gö6976 (Gö, 1 μM), DPI (1 μM), apocynin (10 μM) or NAC (10 mM) for 1 h, and then incubated with 50 μg/ml LTA for the indicated time intervals (b)o r9 0
min (c). The cell lysates were analyzed by Western blotting using an anti-phospho-p300 (p-p300) or GAPDH antibody. d Cells were transfected with scramble
(scra) or p300 siRNA for 24 h, followed by stimulation with 50 μg/ml LTA for 16 h. The conditioned media and cell lysates were collected and analyzed by
gelatin zymography or Western blotting. Data are expressed as the mean of three independent experiments.
*P<0.05;
#P<0.01, as compared with the cells
stimulated with vehicle (b)o rL T A( a, c) alone. The figure represents one of three similar experiments.
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http://www.jneuroinflammation.com/content/9/1/110RBA-1 cells. On the basis of these results and our previ-
ous studies, we suggested that LTA-induced MMP-9 ex-
pression may be mediated through diverse signaling
molecules and pathways, which make joint efforts to en-
hance MMP-9 gene expression and cell migration in
brain astrocytes. However, we will further investigate the
relationship among these different pathways associated
with MMP-9 expression in the future.
The ROS may exert a key role in the normal physio-
logical functions and the inflammatory responses
[22,45]. Several lines of evidence have indicated that
ROS play a causative role in numerous disease patholo-
gies such as ischemia/reperfusion injury and degenera-
tive diseases such as atherosclerosis, arthritis and
neurodegeneration [24,25]. In the brain, the role of ROS
extends to the control of vascular tone, which is tightly
modulated by metabolic activity within neurons [21,23].
Increasing evidence also attributes the cellular damage
in neurodegenerative disorders such as AD to oxidative
stress that is due to the generation of free radicals impli-
cated in brain inflammatory disorders [24,25,45]. The
effects of LTA on ROS generation have been reported in
human renal [27] and tracheal diseases [26]. In this
study, we found and confirmed that LTA-induced MMP-
9 expression is mediated through Nox-dependent ROS
generation in RBA-1 cells (Figure 1). Consistently, many
reports have also shown that ROS are a major signaling
factor that mediates microglial activation induced by in-
flammatory mediators, including LPS [46]. Herein we
are the first group to establish that Nox-dependent ROS
generation contributes to upregulation of MMP-9
induced by LTA in brain astrocytes.
The Nox is considered to be a major source of ROS in
several physiological and pathological processes [21,35].
To date, five Nox isotypes have been discovered, including
Nox1-5 [34]. Several reports have shown that Nox1, Nox2
and Nox4 are expressed in brain cells [21,34], suggesting
that these Nox isotypes may be essential for ROS gener-
ation. However, the role of these enzymes in the upregula-
tion of brain astrocytic MMP-9 is still unclear. Our data
demonstrated that Nox activity is involved in these
responses by pretreatment with a Nox inhibitor DPI (Fig-
ures 2a-c). Moreover, we also found that Nox1, Nox2 and
Nox4 are expressed in RBA-1 cells by RT-PCR (data not
shown). The data of knockdown distinct Nox by transfec-
tion with their respective siRNA indicated that LTA-
induced MMP-9 expression was mediated through activa-
tion of Nox2 in RBA-1 cells (Figure 2d). The data further
showed that phosphorylation and translocation of the
p47
phox subunit, a component of Nox2, is crucial for LTA-
induced these responses (Figure 3). These results are
consistent with previous studies showing that Nox is
expressed in astrocytes, contributes to ROS generation
[47,48] and leads to LPS-induced MMPs expression in
Raw264.7 cells [49]. We also suggested that the LTA-
stimulated p47
phox-dependent Nox2/ROS signal and MMP-
9 expression might be mediated through PKCα in RBA-1
cells (Figure 4). It is consistent with the report indicating
that PKCα can phosphorylate p47
phox,a n di n d u c eb o t hi t s
translocation and then Nox activation in human neutro-
phils [36].
The excessive increase of oxidative stress during injur-
ies can modulate the pattern of gene expression through
various transcription factors. Here we focus on the roles
of transcription factor AP-1, which is well known to be
modulated during oxidative stress associated with in-
flammatory diseases [50]. Accumulating evidence has
shown that MMP-9 is upregulated via an AP-1-
dependent manner in various cell types [5,18]. Upon
stimulation, ATF-2 is known to form heterodimers with
Jun family transcription factors and bind to a specific
AP-1 site in the promoter region of target genes, and
enhances the gene transcription [51]. Our data showed
that ATF-2 phosphorylation is essential for LTA-induced
MMP-9 expression, determined by AP-1 inhibitor
(TSIIA) (Figure 5). Such inhibitory effects were also con-
firmed by transfection with ATF-2 siRNA on MMP-9
expression (Figure 5a). Theses results are consistent with
the mechanisms of MMP-2 expression in human breast
epithelial cells [52]. Moreover, AP-1 binding sites have
been identified in the MMP-9 gene promoter [3], which
might explain the modulation exerted by LTA. Our data
further showed that LTA enhanced phospho-ATF-2
binding to MMP-9 promoter, determined by a ChIP-
PCR assay (Figure 5d), consistent with the responses of
phosphorylation of ATF-2 (Figure 5b). These results sug-
gested that LTA stimulated ATF-2/AP-1 phosphorylation
and binding activity via a ROS-dependent pathway, con-
sistent with ROS-dependent activation of ATF-2 being
involved in H9c2 cells [53].
Moreover, the transcription co-activator p300 is vital
for the co-activation of several transcription factors such
as AP-1 in the transcription machinery, which has a sig-
nificant role in the activation of AP-1-mediated gene ex-
pression for proinflammatory mediators [39]. Our
results indicated that p300 plays an important role in
LTA-induced MMP-9 expression (Figure 6a). Moreover,
we found that LTA increased phosphorylation of p300 is
also mediated through a PKC(α)/Nox(2)/ROS cascade
(Figures 1b and c). The result of p300 siRNA transfec-
tion further confirmed that p300 may contribute to en-
hance transcriptional activation of MMP-9 by LTA
(Figure 6d). It was consistent with previous studies indi-
cating p300-dependent MMP-9 expression by BK or IL-
1β in astrocytes [17,54] and a recent study showing that
ROS-dependent p300 activation leads to cPLA2 expres-
sion by cigarette smoke extract in human tracheal
smooth muscle cells [55]. Subsequently, we also
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tional activity via the same pathway by a wild-type rat
MMP-9 promoter-luciferase reporter plasmid (pGL-
MMP-9-Luc) construct (Figure 7a). These results indi-
cated that LTA-induced MMP-9 expression is mediated
through a PKC(α)-dependent Nox(2)/ROS signal, asso-
ciated with activation of transcription factor ATF-2/AP-1
in RBA-1 cells. Consistently, in rat brain primary cultured
astrocytes, we confirmed that LTA-induced MMP-9 ex-
pression may mediate through the same identified signaling
(Figure 1d).
Cell motility is a fundamental process during embry-
onic development, wound healing, inflammatory
responses and tumor metastasis [56]. It has been
reported that MAPKs, NF-κB, AP-1 and MMP-9 [17,18]
contribute to cell motility in different cell types. In the
study, we further demonstrated that in brain astrocytes,
activation of a Nox-dependent ROS signal linking to
ATF-2/AP-1 and p300, mediated through activation of
PKCα, is essential for LTA-induced MMP-9 gene expres-
sion and cell migration.
Conclusions
In summary, these results demonstrated that LTA
induces MMP-9 expression via sequential activation of
PKCα, p47
phox/Nox2, ROS, and transcription factor
ATF2/AP-1 and co-activator p300, leading to the pro-
motion of astrocytic migration. Although the molecular
basis of the Nox-mediated redox signal in immune, car-
diac and renal diseases is well established, the role of the
Nox-mediated redox signal during acute or chronic
brain inflammation is still unclear. We demonstrated
that the Nox-mediated ROS signal may be a pivot mol-
ecule linking the PKCα and AP-1 signal; this leads to ex-
pression of MMP-9 in CNS infection. Pharmacological
approaches suggest that targeting MMP-9 and its spe-
cific upstream signaling components should yield useful
therapeutic targets for CNS inflammatory diseases upon
infection with gram-positive bacteria.
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